MAPT and Alzheimer disease: Research indicates that the pathological changes underlying AD, including the deposition of amyloid beta (Aβ) protein, tau tangles, and chronic glial cell proliferation, may begin 10–20 years before the onset of clinical symptoms, overlapping with the perimenopausal period (ages 40–60).6